MTP 043
Clinical questions to be addressed:

Who should get PSA screening, and at what age?
Is the level or rate of change of PSA important in determining who should be further evaluated?
When you decide that a patient without known prostate cancer with a rising screening PSA should be evaluated, what should be done and by whom?
What is the management of a patient with a known history of prostate cancer who has a rising PSA but negative scans?
What are the short- and long-term effects of anti-androgen therapy?